Natalia Birgisson received her MD from Stanford where she completed additional training in psychiatry and pediatrics. During the COVID pandemic, Dr. Birgisson served as a frontline physician while helping Doximity build a new telehealth product that was used for over 63M patient calls. Dr. Birgisson joined Doximity as Director of Strategy where she was a member of the core IPO team, helping to take the company public with a market cap over $9B.
Dr. Birgisson is passionate about growing health technology companies that serve children, address the mental health epidemic, and invest in a healthier future. To that end, she enjoys supporting Hopelab’s impact investing team and portfolio companies. In her free time, Dr. Birgisson volunteers as a Court Appointed Special Advocate for children in foster care.